Xencor, Inc. (XNCR)
NASDAQ: XNCR · Real-Time Price · USD
8.54
+0.18 (2.15%)
Jun 20, 2025, 4:00 PM - Market closed
Xencor Employees
Xencor had 250 employees as of December 31, 2024. The number of employees decreased by 30 or -10.71% compared to the previous year.
Employees
250
Change (1Y)
-30
Growth (1Y)
-10.71%
Revenue / Employee
$508,912
Profits / Employee
-$830,384
Market Cap
607.80M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
XNCR News
- 6 weeks ago - Xencor Reports First Quarter 2025 Financial Results - Business Wire
- 7 weeks ago - Xencor Announces Positive Interim Results From First-in-Human Healthy Volunteer Study of XmAb942, a High-Potency Extended Half-Life Anti-TL1A Antibody, in Development for Treatment of Inflammatory Bowel Disease - Business Wire
- 3 months ago - Xencor Appoints Todd Simpson to Board of Directors - Business Wire
- 4 months ago - Xencor Reports Fourth Quarter and Full Year 2024 Financial Results - Business Wire
- 4 months ago - 20 stocks of companies expected to put up numbers to back investors' new ‘growth mindset' - Market Watch
- 7 months ago - Xencor to Participate at Upcoming Investor Conferences - Business Wire
- 7 months ago - Xencor: Plamotamab NHL Data Leads To RA Program Advancement - Seeking Alpha
- 8 months ago - Xencor Reports Third Quarter 2024 Financial Results - Business Wire